Erydel

Recent Finacing

Series B

Recent Raise

$15.1M

EryDel, based in Milan, uses a proprietary device to encapsulate therapeutics in patients' autologous red blood cells and is advancing EryDex Phase III for Ataxia Telangiectasia.

Founded 2007

Molise, Italy

11-50

Private

erydel.com

Highlights

Focus Areas

Biotechnology

Health Care

Pharmaceutical

Recent Investors

F

Financials

$47.5M

Total Raised

2

Funding rounds

4

Investors

Team

Upgrade to view the team

See the team members at Erydel.